Author Archives: health

Abilify for pediatric use

ABILIFY is not approved for pediatric patients with depression. The 2016 NICE guidance for treating psychosis and schizophrenia in children and young people recommended aripiprazole as a second line treatment after risperidone for people between 15 and 17 who are having an acute exacerbation or recurrence of psychosis or schizophrenia. October 20, 2014 but due… Read More: Abilify for pediatric use »